Immunome, Inc.
Immunome, Inc.（IMNM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IMNM · 截至 2026年6月8日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
7
近12个月
买卖比
1.00
Buy/Sell (by trades)
整体情绪
Immunome, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IMNM 季度内部人买卖趋势
IMNM 内幕交易卖出 · IMNM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IMNM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IMNM 高管卖出股份 · IMNM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 15, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 5,000 | $104K | Form 4 |
| Apr 2, 2026 | Higgins Jack Chief Scientific Officer | Sale | 9,438 | $204K | Form 4 |
| Apr 2, 2026 | Rosett Max CFO | Option | 39,713 | $54K | Form 4 |
| Apr 2, 2026 | Rosett Max CFO | Option | 31,848 | $33K | Form 4 |
| Apr 2, 2026 | Rosett Max CFO | Sale | 63,656 | $1.39M⚡ | Form 4 |
| Apr 2, 2026 | Rosett Max CFO | Sale | 1,344 | $30K | Form 4 |
| Mar 30, 2026 | Higgins Jack Chief Scientific Officer | Gift | 6,291 | — | Form 4 |
| Mar 27, 2026 | SIEGALL CLAY B President and CEO · Director | Purchase | 25,450 | $501K | Form 4 |
| Mar 20, 2026 | WAGENHEIM PHILIP Director | Sale | 36,800 | $753K | Form 4 |
| Mar 23, 2026 | WAGENHEIM PHILIP Director | Sale | 28,200 | $582K | Form 4 |
| Mar 11, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $22K | Form 4 |
| Mar 10, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $22K | Form 4 |
| Dec 30, 2025 | SIEGALL CLAY B President and CEO · Director | Purchase | 4,729 | $100K | Form 4 |
| Dec 22, 2025 | Barchas Isaac Director | Sale | 371,949 | $8.08M⚡ | Form 4 |
| Dec 22, 2025 | Barchas Isaac Director | Sale | 11,251 | $251K | Form 4 |
| Dec 19, 2025 | Higgins Jack Chief Scientific Officer | Gift | 1,000 | — | Form 4 |
| Dec 19, 2025 | Higgins Jack Chief Scientific Officer | Gift | 1,000 | — | Form 4 |
| Dec 19, 2025 | Higgins Jack Chief Scientific Officer | Gift | 1,000 | — | Form 4 |
| Dec 19, 2025 | Higgins Jack Chief Scientific Officer | Gift | 1,000 | — | Form 4 |
| Dec 19, 2025 | SIEGALL CLAY B President and CEO · Director | Purchase | 7,278 | $149K | Form 4 |
| Dec 19, 2025 | SIEGALL CLAY B President and CEO · Director | Gift | 200,000 | — | Form 4 |
| Dec 19, 2025 | Tsai Philip Chief Technical Officer | Purchase | 10,000 | $205K | Form 4 |
| Dec 18, 2025 | SIEGALL CLAY B President and CEO · Director | Purchase | 46,511 | $1000K | Form 4 |
| Sep 10, 2025 | Higgins Jack Chief Scientific Officer | Option | 22,000 | $30K | Form 4 |
| Jun 3, 2025 | BIENAIME JEAN JACQUES Director | Purchase | 5,000 | $47K | Form 4 |
SIEGALL CLAY B
President and CEO · Director
日期
Mar 27
股数
25,450
均价
$19.67
总金额
$501K
SIEGALL CLAY B
President and CEO · Director
日期
Dec 30
股数
4,729
均价
$21.15
总金额
$100K
SIEGALL CLAY B
President and CEO · Director
日期
Dec 19
股数
7,278
均价
$20.48
总金额
$149K
SIEGALL CLAY B
President and CEO · Director
日期
Dec 18
股数
46,511
均价
$21.50
总金额
$1000K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IMNM 内幕交易
IMNM 内幕交易
Immunome, Inc.（IMNM）内幕交易数据来源于公司内部人（包括Higgins Jack (Chief Scientific Officer), SIEGALL CLAY B (President and CEO · Director), Rosett Max (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IMNM内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Immunome, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IMNM 内幕交易 · 5个问题Immunome, Inc.（IMNM）的内部人包括高管和董事，如Higgins Jack (Chief Scientific Officer), SIEGALL CLAY B (President and CEO · Director), Rosett Max (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026